ArticleScience advances2024

Lipopolyplex-formulated mRNA cancer vaccine elicits strong neoantigen-specific T cell responses and antitumor activity.

Ting Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.